TITLE

Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide

AUTHOR(S)
Shi Yu Yang; Sales, Kevin M.; Fuller, Barry J.; Seifalian, Alexander M.; Winslet, Marc C.
PUB. DATE
January 2008
SOURCE
Molecular Cancer;2008, Vol. 7, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The resistance of tumour cells to apoptosis is a major contributor to the limited effectiveness of chemotherapies. Insulin-like growth factor I (IGF-I) has potential to protect cancer cells from variety of apoptotic challenges. This study was carried out to investigate the effect of a novel IGF-I receptor antagonist on apoptosis in colon cancer cells. Results: We have designed and synthesised a novel antagonist of IGF-I receptor. The effect of this antagonist on human colon cancer cell proliferation was examined by a non-radioactive assay; the apoptosis was revealed by determining the activities of cellular caspases3/7, 8 and 9. The apoptosis pathways were investigated by examining the levels of pro-apoptosis proteins with Western blotting. Following 40 hours treatment with the novel antagonist peptide, colon cancer cell Caspase 3/7 activities increased 2-7 times; Caspase 8 activities increased 2-5 times and Caspase 9 increased 1.2-1.6 times. The proliferation of cancer cell was inhibited by 14-15%. The data showed that the antagonist induced colon cancer cell apoptosis and inhibited cancer cell proliferation. The different changes of Caspase 3/7, 8 and 9 activities suggested that the extrinsic pathways may play a major role in the antagonist peptide-induced apoptosis. Conclusion: This is the first report on this novel antagonist to induce human colon cancer cell apoptosis and inhibit cancer cell proliferation. These results suggest that IGF-I receptor antagonists may have the potential to be developed as a novel therapy for colon cancers in the future.
ACCESSION #
35703537

Tags: ENZYME inhibitors;  SOMATOMEDIN;  APOPTOSIS;  CANCER cells -- Growth -- Regulation;  CANCER cells -- Proliferation;  COLON (Anatomy) -- Cancer;  PEPTIDES

 

Related Articles

  • Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis. Teng, Brian P.; Heffler, Melissa D.; Lai, Eric C.; Zhao, Ya-Li; LeVea, Charles M.; Golubovskaya, Vita M.; BullardDunn, Kelli M. // Anti-Cancer Agents in Medicinal Chemistry;2011, Vol. 11 Issue 7, p620 

    Hyaluronan (HA) and hyaluronan synthases (HAS) have been implicated in cancer growth and progression. We previously have shown that HAS3 and HA mediate tumor growth in SW620 colon cancer cells, but the mechanism remains poorly understood. In addition, the effect of HAS3 inhibition on tumor...

  • The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells. Kwan, Hiu-Yee; Yang, Zhijun; Fong, Wang-Fun; Hu, Yong-Mei; Yu, Zhi-Ling; Hsiao, Wen-Luan // Journal of Gastroenterology;Feb2013, Vol. 48 Issue 2, p182 

    Background: Fatty acid synthase (FAS) inhibitors could be a therapeutic target in cancer treatment. However, only a few FAS inhibitors showing clinical potential have been reported. Oridonin is a diterpenoid isolated from Rabdosia rubescens. Although it has antiproliferative activity in cancers,...

  • The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival. Evans, C.; Morrison, I.; Heriot, A. G.; Bartlett, J. B.; Finlayson, C.; Dalgleish, A. G.; Kumar, D. // British Journal of Cancer;5/22/2006, Vol. 94 Issue 10, p1412 

    Colorectal cancer development is associated with a shift in host immunity with suppression of the cell-mediated immune system (CMI) and a predominance of humoral immunity (HI). Tumour progression is also associated with increased rates of cell proliferation and apoptosis. The aim of this study...

  • Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. Zhou, Fang; Zhou, Hong; Wang, Ting; Mu, Yuan; Wu, Biao; Guo, Dong-lin; Zhang, Xian-mei; Wu, Ying // Acta Pharmacologica Sinica;Jan2012, Vol. 33 Issue 1, p120 

    Aim:Epigallocatechin-3-gallate (EGCG) is the major polyphenolic constituent in green tea. The aim of this study is to investigate the effects of EGCG on proliferation and migration of the human colon cancer SW620 cells.Methods:Proliferation and migration of SW620 cells were induced by the...

  • Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Yao, M.; Lam, E. C.; Kelly, C. R.; Zhou, W.; Wolfe, M. M. // British Journal of Cancer;2/9/2004, Vol. 90 Issue 3, p712 

    Nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to reduce the risk and mortality of colorectal cancer (CRC) by inhibiting the activity of cyclooxygenase (COX). The present studies were directed to determine whether selective COX-2 inhibition reduces CRC tumour cell proliferation...

  • Oral presentations.  // Annals of Oncology;May2011 Supplement 5, Vol. 22 Issue suppl_5, pv10 

    No abstract available.

  • The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models. Na, Young-Soon; Jung, Kyung-Ah; Kim, Seung-Mi; Hong, Yong; Ryu, Min-Hee; Jang, Se; Moon, Dae; Cho, Dong-Hyung; Kim, Jin; Lee, Jung; Kim, Tae // Cancer Chemotherapy & Pharmacology;Aug2011, Vol. 68 Issue 2, p389 

    Purpose: Histone deacetylase inhibitors (HDACIs), such as PXD101 and suberoylanilide hydroxamic acid, inhibit proliferation and stimulate apoptosis of tumor cells. The enhanced effectiveness of chemotherapy or radiotherapy when combined with HDACIs has been observed in several cancers. In this...

  • microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Zhang, N; Li, X; Wu, C W; Dong, Y; Cai, M; Mok, M T S; Wang, H; Chen, J; Ng, S S M; Chen, M; Sung, J J Y; Yu, J // Oncogene;10/17/2013, Vol. 32 Issue 42, p5078 

    Using microRNA (miRNA) expression array, we identified that miR-7 was deregulated in colorectal cancer (CRC). We studied the biological role and molecular target of miR-7 in CRC. miR-7 was downregulated in six out of seven colon cancer cell lines. Ectopic expression of miR-7 suppressed colon...

  • MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang, Jie-Ting; Wang, Ji-Lin; Du, Wan; Hong, Jie; Zhao, Shu-Liang; Wang, Ying-Chao; Xiong, Hua; Chen, Hui-Min; Fang, Jing-Yuan // Carcinogenesis;Aug2011, Vol. 32 Issue 8, p1207 

    Aberrant methylation has been shown to trigger the inactivation of tumor suppressor genes during tumorigenesis. MicroRNAs (miRNAs) have been found deregulated in human colorectal cancer (CRC), and some of them may function as tumor suppressor genes. Here, we investigated CpG island promoter...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics